Calacanis, General Catalyst's Taneja, and McKinsey's Sternfels discussed how AI is reshaping technology and the labor force.
Stephens Group Portfolio Company Catalyst Acoustics Group to Be Acquired by KPS Capital Partners, LP
The Stephens Group, LLC ("Stephens Group") announced today that KPS Capital Partners, LP ("KPS") has signed a definitive agreement to acquire its portfolio company Catalyst Acoustics Group ("Catalyst" ...
Jeffrey Del Carmen, Chief Commercial Officer of Catalyst Pharmaceuticals ( CPRX +0.06%), exercised and immediately sold ...
NEW YORK--(BUSINESS WIRE)--Catalyst, a leading Customer Success software company, recently named by peer-to-peer review site G2 as a leader in customer success and customer revenue, today named Mark ...
RC Capital, Mutual Capital Partners and Western Alliance Bank reinforce long-term confidence in Catalyst’s vision and leadership; Dr. Theodore Blaine joins Catalyst board of directors NAPLES, ...
Achieved Record Q2 2025 Total Revenues of $146.6 Million, an Increase of 19.4% YoY, Marking Another Quarter of Consecutive Growth Reported Record First Half 2025 Total Revenues of $288.0 Million, an ...
CORAL GABLES, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals (CPRX), Inc. today reported financial results for the fourth quarter and full year 2024 and provided a business update.
Estonian company Up Catalyst just raised $4.3 million to make graphite with captured carbon. Graphite is used in lithium-ion batteries but it's currently mined or derived from fossil fuels. Check out ...
Innovation Catalyst is heading down a new path with a fresh CEO at the helm, a bigger board of directors overseeing efforts and a plan to spin up a new for-profit venture capital fund. The nonprofit ...
Hemant Taneja, CEO and managing director of venture capital firm General Catalyst, and Dr. Marc Harrison, former CEO of Intermountain Health, announced the formation of a new business venture owned by ...
Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) announced in Q3 CY2025, but sales were flat year on year at $76.32 million. On the other hand, next quarter’s revenue guidance of $73.5 ...
CORAL GABLES, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), today reported financial results for the first quarter of 2025 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results